Medical Health & Life Science Research News

Atopic dermatitis therapeutics strategies and product pipeline review 2017 just published

Atopic dermatitis therapeutics strategies and product pipeline review 2017 just published

The key factors which are anticipated to drive atopic dermatitis market include increase in global population, improvement in the global health care expenditure, accelerated economic growth, pollution and climatic factors and role of triggers. Some of the significant developments of this industry include introduction of new biologics, biomarker in atopic dermatitis and opportunity for new entrants.

- Advertisement -
- Membership expired -

Pune, India, 30th August 2017: WiseGuyReports announced addition of new report, titled “Global Atopic Dermatitis Market Report: 2016 Edition”. 

Atopic dermatitis (AD) is a chronic, inflammatory skin disease of unknown origin that usually starts in early infancy, but also affects a substantial number of adults. Atopic dermatitis is a long lasting skin disease that affects a large percentage of the world's population and is a special type of hypersensitivity that is associated with asthma, inhalant allergies (hay fever), and a chronic dermatitis.

The symptoms of atopic dermatitis are itching, red to brownish grey patches and small raised bumps.

- Advertisement -
- Membership expired -

Sample report @ www.wiseguyreports.com/sample-requ…port-2016-edition             

The main cause of atopic dermatitis is unknown but it is assumed to be caused due to genetics, dry skin and environmental conditions. Multiple factors can trigger or worsen atopic dermatitis, including low humidity, seasonal allergies, exposure to harsh soaps and detergents, and cold weather.

There has been no specified biologic till now for atopic dermatitis. But recent efforts by many companies have shown positive results and the first biologic may get launched in 2017.

After that many other products are still in pipeline.

However, the challenge to be faced ahead is time to be taken in drug adoption, high price and legal regulations.

This report offers a comprehensive analysis of the atopic dermatitis market. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth.

On the contention front, the global market is reined by few major players namely Sanofi, Glaxo Smithkline (GSK), AstraZeneca and Roche Holding. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.

Table of Content: Key Points

  1. Atopic Dermatitis: An Introduction

    1.1 Symptoms of Atopic Dermatitis

    1.2 Causes of Atopic Dermatitis 8

    1.3 Factors which worsen Atopic Dermatitis

    1.4 Different Types of Eczema

    1.5 Skin Features of Atopic Dermatitis

    1.6 Stages of Atopic Dermatitis

    1.7 Prevention of Atopic Dermatitis

    1.8 Treatment of Atopic Dermatitis

  1. Atopic Dermatitis – Global Market

    2.1 Global Atopic Dermatitis Treatment Market by Value

    2.2 Global Adults Affected with Atopic Dermatitis

    2.3 Global Adults Diagnosed with Atopic Dermatitis

    2.4 Global Adults with Moderate to Severe Atopic Dermatitis

    2.5 Global Adults Refractory to Topical Therapies

  1. Atopic Dermatitis - Regional Markets

    3.1 The US Atopic Dermatitis Market

      3.1.1 The US Atopic Dermatitis Treatment Market by Value

      3.1.2 The US Adults Affected with Atopic Dermatitis

      3.1.3 The US Adults Diagnosed with Atopic Dermatitis

      3.1.4 The US Adults with Moderate to Severe Atopic Dermatitis

      3.1.5 The US Adults Refractory to Topical Therapies by Volume

      3.1.6 The US Treated Patients by Volume

      3.1.7 Severity Level for Atopic Dermatitis Patients for Different Age Groups

    3.2 European Union Atopic Dermatitis Market

      3.2.1 EU Atopic Dermatitis Treatment Market by Value

      3.2.2 EU Adults Affected with Atopic Dermatitis

      3.2.3 EU Adults Diagnosed with Atopic Dermatitis

      3.2.4 EU Adults with Moderate to Severe Atopic Dermatitis

      3.2.5 EU Adult Refractory to Topical Therapies by Volume

      3.2.6 EU Treated Patients by Volume

    3.3 ROW Atopic Dermatitis Market

      3.3.1 ROW Atopic Dermatitis Treatment Market by Value

      3.3.2 ROW Adults with Moderate to Severe Atopic Dermatitis

      3.3.3 ROW Adults Refractory to Topical Therapies by Volume

  1. Market Dynamics

    4.1 Growth Drivers

      4.1.1 Increase in Global Population

      4.1.2 Increase in Health Care Expenditure

      4.1.3 Accelerated Economic Growth

      4.1.4 Pollution and Climate Factors

…Continued        

 

Access report @ www.wiseguyreports.com/reports/161…port-2016-edition            

  

News From

Wise Guy Reports - Market ResearchWise Guy Reports
Category: Market Research Publishers and RetailersCompany profile: Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs. Our Market Research Reports and Consulting Services  ...